FK960 [N-(4-acetyl-1-piperazinyl)-p-fluorobenzamide monohydrate], a novel potential antidementia drug, restores the regional cerebral blood flow response abolished by scopolamine but not by HA-966: a positron emission tomography study with unanesthetized rhesus monkeys

Publication | Closed Access

DOI

Citations

References

1999

Year

Hideo Tsukada, Shunji Yamazaki, Akihiro Noda, Tatsuo Inoue, Nobuya Matsuoka, Takeharu Kakiuchi, Shingo Nishiyama, Shintaro Nishimura

Brain Research

Unanesthetized Rhesus MonkeysMedicineNeuropharmacologyNeuroprotectionNeuroscienceNeurologyPharmacotherapyCerebral Blood FlowPharmacologyDrug DiscoveryCerebral Vascular Regulation